HOME>News Release>Mitsubishi Pharma Corporation
News Release : Mitsubishi Pharma Corporation 2006
2006
- 11/9
- On November 9, 2006, Mitsubishi Pharma Corporation announces its consolidated and non-consolidated financial results for the sixth-month period ended September 30,2006.
- 11/8
- Conclusion of global licensing agreement for Kremezin, a therapeutic agent for chronic kidney disease
- 7/31
- Establishment of U.S. Investment Company
- 7/31
- On July 31, 2006, Mitsubishi Pharma Corporation announces its consolidated financial results for the three-month period ended June 30,2006.
- 5/11
- On May 11, 2006, Mitsubishi Pharma Corporation announced its consolidated and non-consolidated financial results for the fiscal year ended March 31,2006.
- 5/11
- Establishment of a Pharmaceutical Development Subsidiary in China
- 3/22
- MP-Technopharma to Start Contract Manufacturing of
Chugai Pharmaceutical's Four Prescription Pharmaceutical Products
- 2/23
- Conclusion of license agreement for internal hemorrhoid sclerotherapy agent Zione Injection in South Korea
